Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AUPH | US
-0.16
-0.99%
Healthcare
Biotechnology
30/06/2024
24/04/2026
15.98
16.03
16.34
15.88
Aurinia Pharmaceuticals Inc. a commercial-stage biopharmaceutical company focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co. Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria Canada.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
26.7%1 month
34.5%3 months
34.8%6 months
38.1%-
15.15
2.82
0.24
0.16
-7.69
3.78
-
-27.15M
2.28B
2.28B
-
-0.77
-
37.80
-13.30
5.52
5.09
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.32
Range1M
3.06
Range3M
3.36
Rel. volume
1.13
Price X volume
18.74M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc. | RLAY | Biotechnology | 15.13 | 2.46B | 0.27% | n/a | 7.50% |
| Kodiak Sciences Inc | KOD | Biotechnology | 44.84 | 2.36B | -0.82% | n/a | 81.94% |
| Tarsus Pharmaceuticals Inc | TARS | Biotechnology | 61.45 | 2.34B | 0.79% | n/a | 28.62% |
| Arcus Biosciences Inc | RCUS | Biotechnology | 25.5 | 2.33B | 1.47% | n/a | 1.73% |
| Zai Lab Limited | ZLAB | Biotechnology | 22.77 | 2.31B | 4.07% | n/a | 11.88% |
| Spruce Biosciences Inc | SPRB | Biotechnology | 54.37 | 2.25B | 0.67% | n/a | 6.24% |
| BEAM THERAPEUTICS INC. | BEAM | Biotechnology | 27.11 | 2.23B | -10.11% | n/a | 19.35% |
| Ultragenyx Pharmaceutical Inc | RARE | Biotechnology | 24.1 | 2.22B | -0.74% | n/a | 214.27% |
| Celldex Therapeutics Inc | CLDX | Biotechnology | 33.29 | 2.21B | -0.77% | n/a | 0.29% |
| DBV Technologies S.A | DBVT | Biotechnology | 19.8 | 2.11B | 2.38% | n/a | 16.59% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| HNI Corporation | HNI | Building Products & Equipment | 37.7 | 1.78B | 1.32% | 22.12 | 76.47% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.6 | 1.46B | 3.03% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 39.11 | 1.23B | -1.21% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 32.87 | 951.75M | 0.70% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.44 | 790.55M | 1.30% | 11.62 | 116.21% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 17.7 | 737.79M | 2.31% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.01 | 694.62M | -0.17% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 20.33 | 528.66M | -1.26% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 26.1 | 521.76M | -0.91% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 23.53 | 390.77M | -0.88% | 34.27 | 26.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.69 | - | Cheaper |
| Ent. to Revenue | 3.78 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.82 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 34.76 | - | Lower Risk |
| Debt to Equity | 0.24 | -1.23 | Expensive |
| Debt to Assets | 0.16 | 0.25 | Cheaper |
| Market Cap | 2.28B | - | Emerging |